Skip to main content

Retraction Note: Green synthesis of oncolytic Newcastle disease virus-loaded thiolated chitosan nanoformulation for CD44 targeted delivery and sustained release of virus in cervical cancer xenografts

The Original Article was published on 12 August 2023

Retraction: Cancer Nanotechnology (2023) 14:71 https://doi.org/10.1186/s12645-023-00220-8

The Editors-in-Chief have retracted this article. After publication, concerns were raised regarding overlapping images in the presented data. Specifically:

Multiple images in Fig. 8a appear highly similar to those in Fig. 17 in Naseer et al. (2023), representing different groups.

Multiple images in Fig. 8b appear highly similar to those in Fig. 18 in Naseer et al. (2023), representing different groups.

  • Fig. 8a D1 appears highly similar to Fig. 8b D3.

  • Fig. 8a E1 and E2 appear to overlap with different magnification.

  • Fig. 9a A5 insert (low magnification image) appears highly similar to that in B5.

  • Fig. 9a A9 and b D7 appear to overlap with different contrast.

  • Fig. 9a A10, A12 and B10 appear to overlap.

  • Fig. 9a B1 and b C1, C3 appear to overlap with different magnification.

  • Fig. 9a B3 and b C2, D2 appear to overlap with different magnification and contrast.

  • Fig. 9a B4 and b D4 appear to overlap.

  • Fig. 9a B10 and B11 appear to overlap.

Additionally, the rat body weight data presented in Fig. 5a (~ 160 g at week 1) appear to be contrary to the description in the Methods (200–250 g).

The Editors-in-Chief therefore no longer have confidence in the presented data.

None of the authors have responded to any correspondence from the editor or publisher about this retraction notice.

Reference

  • Naseer F, Kousar K, Abduh MS et al (2023) Evaluation of the anticancer potential of CD44 targeted vincristine nanoformulation in prostate cancer xenograft model: a multi-dynamic approach for advanced pharmacokinetic evaluation. Cancer Nanotechnol 14:65. https://doi.org/10.1186/s12645-023-00218-2

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Kousain Kousar or Tahir Ahmad.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Kousar, K., Naseer, F., Abduh, M.S. et al. Retraction Note: Green synthesis of oncolytic Newcastle disease virus-loaded thiolated chitosan nanoformulation for CD44 targeted delivery and sustained release of virus in cervical cancer xenografts. Cancer Nano 15, 40 (2024). https://doi.org/10.1186/s12645-024-00279-x

Download citation

  • Published:

  • DOI: https://doi.org/10.1186/s12645-024-00279-x